In addition to ctDNA, pre-surgery plasma samples were analyzed for the presence of the following six tumor biomarkers: CA125, CA19-9, CYFRA21-1, CEA, NSE, and squamous cell carcinoma antigen (SCC) (Supplementary Table S6). This evidence concerns the gene CEACAM5 and neoplasm.